Literature DB >> 7764389

Extracellular production of human hepatitis B virus preS2 antigen as hybrid proteins with Bacillus subtilis alpha-amylases in high-salt-concentration media.

K Honda1, H Fujieda, K Ogawa, M Imai, H Yamamoto, T Ikeda, K Yamane.   

Abstract

To produce PreS2 antigen of human hepatitis B virus extra-cellularly in Bacillus subtilis, it was fused with the COOH-termini of B. subtilis alpha-amylases of 522 (Amy+), 467 (Amy+) and 443 (Amy-) amino acids. Among them, alpha-amylase-A467, which has 467 amino acids, was a relatively stable carrier when the cells were cultured in Luria-Bertani (LB) medium. The alpha-amylase-A443-PreS2 hybrid protein (Amy-) was quickly degraded. The alpha-amylase-A522-PreS2 hybrid was most efficiently produced when a B. subtilis transformant of a protease-super-deficient mutant was cultured in the presence of 0.5 M sodium sulphate. The production of A522-PreS2 hybrid protein under such conditions reached 5-10 mg/l and was eight, and 200-500 times higher than those obtained by the transformants of an alkaline/neutral protease-deficient mutant of B. subtilis, and a wild-type strain, in LB medium, respectively.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7764389     DOI: 10.1007/BF00170390

Source DB:  PubMed          Journal:  Appl Microbiol Biotechnol        ISSN: 0175-7598            Impact factor:   4.813


  16 in total

1.  Hemagglutination assay of polypeptide coded by the pre-S region of hepatitis B virus DNA with monoclonal antibody: correlation of pre-S polypeptide with the receptor for polymerized human serum albumin in serums containing hepatitis B antigens.

Authors:  H Okamoto; M Imai; S Usuda; E Tanaka; K Tachibana; S Mishiro; A Machida; T Nakamura; Y Miyakawa; M Mayumi
Journal:  J Immunol       Date:  1985-02       Impact factor: 5.422

2.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Hybrid alpha-amylases produced by transformants of Bacillus subtilis. II. Immunological and chemical properties of alpha-amylases produced by the parental strains and the transformants.

Authors:  H Matsuzaki; K Yamane; B Maruo
Journal:  Biochim Biophys Acta       Date:  1974-09-13

5.  A receptor for polymerized human and chimpanzee albumins on hepatitis B virus particles co-occurring with HBeAg.

Authors:  M Imai; Y Yanase; T Nojiri; Y Miyakawa; M Mayumi
Journal:  Gastroenterology       Date:  1979-02       Impact factor: 22.682

6.  Construction of a Bacillus subtilis double mutant deficient in extracellular alkaline and neutral proteases.

Authors:  F Kawamura; R H Doi
Journal:  J Bacteriol       Date:  1984-10       Impact factor: 3.490

7.  Typing hepatitis B virus by homology in nucleotide sequence: comparison of surface antigen subtypes.

Authors:  H Okamoto; F Tsuda; H Sakugawa; R I Sastrosoewignjo; M Imai; Y Miyakawa; M Mayumi
Journal:  J Gen Virol       Date:  1988-10       Impact factor: 3.891

8.  Changes in the properties and molecular weights of Bacillus subtilis M-type and N-type alpha-amylases resulting from a spontaneous deletion.

Authors:  K Yamane; Y Hirata; T Furusato; H Yamazaki; A Nakayama
Journal:  J Biochem       Date:  1984-12       Impact factor: 3.387

9.  Stable hyper-production of Escherichia coli beta-lactamase by Bacillus subtilis grown on a 0.5 M succinate-medium using a B. subtilis alpha-amylase secretion vector.

Authors:  K Nakamura; T Furusato; T Shiroza; K Yamane
Journal:  Biochem Biophys Res Commun       Date:  1985-04-30       Impact factor: 3.575

10.  A hepatitis B surface antigen polypeptide (P31) with the receptor for polymerized human as well as chimpanzee albumins.

Authors:  A Machida; S Kishimoto; H Ohnuma; H Miyamoto; K Baba; K Oda; T Nakamura; Y Miyakawa; M Mayumi
Journal:  Gastroenterology       Date:  1983-08       Impact factor: 22.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.